Aurinia Pharmaceuticals Faces Downgrade, Halts Drug Development
Aurinia Pharmaceuticals downgraded by Bloom Burton & Co. as they halt drug development and implement workforce reduction. Implications for future ...
- Latest
- Trending
Aurinia Pharmaceuticals downgraded by Bloom Burton & Co. as they halt drug development and implement workforce reduction. Implications for future ...
Crypto analyst predicts significant growth for the Stacks (STX) project on the Bitcoin blockchain due to Bitcoin's strong market performance ...
The construction of new homes in the US plummeted 14.8% in January as builders scaled back, citing wintry weather as ...
Discover the strategies for accessing private markets through pre-IPO investing. Leverage platforms, diversify portfolios, conduct due diligence, and seek expert ...
Opendoor Technologies Inc. reported strong Q4 performance, with revenue reaching $870M and a solid contribution margin. The company anticipates growth ...
Incannex Healthcare makes breakthrough in smoking cessation drug program as FDA approves clinical trials for CannQuit-N chewing gum.
Bitcoin breaks above $50,000 for the first time in over two years, signaling a potent resurgence. Analysts predict a potential ...
Dropbox's Q4 earnings beat expectations with higher EPS and revenue, but concerns over declining ARR and paying users caused a ...
Asus has launched its new ROG G22 gaming desktop in India, featuring a compact design, powerful performance, and customizable lighting ...
XRP's fall from the second-largest cryptocurrency to sixth position in market cap sparks concern, but there are speculations about its ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.